Skip to main content

Table 1 Pharmacokinetic parameters of HB-002.1

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

AUC (g · days/ml)

MRT (hr)

T1/2(hr)

Cmax(μg/ml)

81.46

180

120

20.27

  1. Note: AUC, area under the curve concentration; MRT, mean.
  2. residence time; T1/2, half-life; Cmax: maximal concentration.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us